Cokmert, S. Et Al. 2021. Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations. WEST INDIAN MEDICAL JOURNAL , vol.69, no.3 , 148-153.

Cokmert, S., Veral, A., Akyurek, N., Kececi, S. D., Sivrikoz, O., Yilmaz, E., ... Tanriverdi, O.(2021). Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations. WEST INDIAN MEDICAL JOURNAL , vol.69, no.3, 148-153.

Cokmert, S. Et Al. "Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations," WEST INDIAN MEDICAL JOURNAL , vol.69, no.3, 148-153, 2021

Cokmert, S. Et Al. "Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations." WEST INDIAN MEDICAL JOURNAL , vol.69, no.3, pp.148-153, 2021

Cokmert, S. Et Al. (2021) . "Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations." WEST INDIAN MEDICAL JOURNAL , vol.69, no.3, pp.148-153.

@article{article, author={S. Cokmert Et Al. }, title={Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations}, journal={WEST INDIAN MEDICAL JOURNAL}, year=2021, pages={148-153} }